Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arun Elangovan

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
The Journal of Urology|July 25, 2025
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME StudyBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.
Endocrine Oncology (Bristol, England)|July 3, 2026
Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancerMathew Gorman, Nawaid Usmani, Michael N Pollak, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
The Journal of Urology|July 25, 2025
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME StudyBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.
Endocrine Oncology (Bristol, England)|July 3, 2026
Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancerMathew Gorman, Nawaid Usmani, Michael N Pollak, et al.
Pageof 5